HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wilko Weichert Selected Research

Semiconductors

9/2020Immunohistological Expression of SOX-10 in Triple-Negative Breast Cancer: A Descriptive Analysis of 113 Samples.
5/2015Semiconductor-based sequencing of formalin-fixed, paraffin-embedded colorectal cancer samples.
10/2014Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.
11/2013Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wilko Weichert Research Topics

Disease

203Neoplasms (Cancer)
03/2022 - 06/2003
44Adenocarcinoma
05/2022 - 11/2004
36Carcinoma (Carcinomatosis)
01/2022 - 09/2003
26Breast Neoplasms (Breast Cancer)
01/2022 - 06/2003
24Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2006
20Neoplasm Metastasis (Metastasis)
12/2021 - 02/2008
19Squamous Cell Carcinoma of Head and Neck
01/2022 - 08/2011
18Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2005
15Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2005
14Stomach Neoplasms (Stomach Cancer)
08/2022 - 04/2006
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 12/2012
9Renal Cell Carcinoma (Grawitz Tumor)
03/2022 - 12/2008
9Sarcoma (Soft Tissue Sarcoma)
01/2022 - 07/2013
9Lung Neoplasms (Lung Cancer)
07/2021 - 11/2013
8Prostatic Neoplasms (Prostate Cancer)
11/2019 - 08/2004
7Microsatellite Instability
01/2022 - 10/2019
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 10/2015
7Carcinogenesis
11/2021 - 04/2006
7Lymphatic Metastasis
01/2020 - 04/2006
7Residual Neoplasm
06/2018 - 06/2009
5Colonic Neoplasms (Colon Cancer)
01/2022 - 09/2005
5Triple Negative Breast Neoplasms
12/2021 - 10/2016
5Neuroendocrine Carcinoma
10/2021 - 12/2011
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2020 - 12/2015
4Disease Progression
01/2022 - 04/2005
4Hypoxia (Hypoxemia)
01/2022 - 03/2007
4Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 09/2008
4Inflammation (Inflammations)
10/2020 - 11/2014
4Esophageal Squamous Cell Carcinoma
12/2019 - 03/2015
3Cholangiocarcinoma
05/2022 - 07/2014
3Leiomyoma (Uterine Fibroids)
01/2022 - 07/2005
3Fibrosis (Cirrhosis)
10/2020 - 01/2017
3Hepatocellular Carcinoma (Hepatoma)
03/2020 - 07/2009
3Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2018 - 02/2014
3Tics (Tic)
01/2017 - 10/2011
3Esophageal Neoplasms (Esophageal Cancer)
03/2015 - 06/2008

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2005
37Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2009
25ParaffinIBA
05/2022 - 09/2003
24Formaldehyde (Formol)FDA Link
05/2022 - 09/2003
16Messenger RNA (mRNA)IBA
08/2021 - 02/2008
13Biological ProductsIBA
10/2021 - 04/2008
12Pharmaceutical PreparationsIBA
01/2022 - 11/2003
12Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2011
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2009
11Immune Checkpoint InhibitorsIBA
01/2022 - 11/2016
11RNA (Ribonucleic Acid)IBA
11/2021 - 12/2009
11Protein Isoforms (Isoforms)IBA
01/2018 - 06/2003
9Histone Deacetylases (Histone Deacetylase)IBA
01/2019 - 02/2008
9MicroRNAs (MicroRNA)IBA
01/2019 - 02/2010
9Histone Deacetylase InhibitorsIBA
01/2019 - 02/2008
8B7-H1 AntigenIBA
12/2021 - 01/2016
8Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2020 - 06/2003
8Phosphotransferases (Kinase)IBA
01/2020 - 04/2005
8LigandsIBA
01/2019 - 08/2011
7AnthracyclinesIBA
10/2021 - 01/2009
7Hormones (Hormone)IBA
01/2021 - 01/2009
6GemcitabineFDA Link
01/2021 - 07/2017
5Cetuximab (Erbitux)FDA Link
01/2020 - 11/2010
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 09/2011
5ErbB Receptors (EGF Receptor)IBA
01/2018 - 01/2010
5taxaneIBA
01/2017 - 01/2009
4tyrosine receptor (receptor, tyrosine)IBA
01/2022 - 01/2016
4Calcibiotic Root Canal SealerIBA
01/2022 - 11/2009
4Phenobarbital (Luminal)FDA Link
12/2021 - 06/2013
4SynaptophysinIBA
12/2021 - 01/2017
4pembrolizumabIBA
11/2021 - 01/2019
4Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 01/2017
4Paclitaxel (Taxol)FDA LinkGeneric
08/2018 - 06/2009
4Tyrosine Kinase InhibitorsIBA
01/2018 - 02/2015
4Progesterone Receptors (Progesterone Receptor)IBA
01/2017 - 01/2009
4Indicators and Reagents (Reagents)IBA
03/2015 - 02/2008
4Matrix Metalloproteinases (MMPs)IBA
10/2013 - 08/2010
4Estrogen ReceptorsIBA
03/2011 - 06/2003
4ELAV-Like Protein 1IBA
02/2008 - 01/2004
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2007 - 06/2003
4Polo-Like Kinase 1IBA
04/2006 - 08/2004
3AntigensIBA
01/2022 - 10/2017
3IntegrinsIBA
01/2022 - 01/2017
3Eosine Yellowish-(YS) (Eosin)IBA
12/2021 - 05/2013
3LipidsIBA
12/2021 - 09/2008
3Contrast MediaIBA
03/2020 - 01/2008
3AmphiregulinIBA
01/2019 - 08/2011
3olaparibIBA
01/2019 - 06/2016
3human ERBB2 proteinIBA
01/2019 - 01/2009
3folfirinoxIBA
01/2019 - 07/2017
3Transcription Factors (Transcription Factor)IBA
11/2018 - 03/2007
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 07/2009
3leptomycin BIBA
07/2011 - 02/2008
2Peptides (Polypeptides)IBA
05/2022 - 12/2012

Therapy/Procedure

89Therapeutics
03/2022 - 08/2004
28Drug Therapy (Chemotherapy)
10/2021 - 01/2009
22Neoadjuvant Therapy
01/2022 - 01/2009
12Radiotherapy
11/2021 - 03/2012
11Immunotherapy
10/2020 - 01/2016
6Chemoradiotherapy
01/2022 - 06/2011
4Lasers (Laser)
05/2022 - 10/2016
4Semiconductors
09/2020 - 11/2013
4Precision Medicine
12/2019 - 08/2015
3Heterologous Transplantation (Xenotransplantation)
01/2017 - 02/2016